Alkosign reappoints five directors, schedules 6th AGM for September 29
- Alkosign Ltd board reappointed five directors for five-year terms
- Remuneration fixes require shareholder approval at the upcoming AGM
- Sixth annual general meeting scheduled for September 29, 2026
- Director's Report for FY26 was approved during the September 4 meeting

*this image is generated using AI for illustrative purposes only.
Alkosign Ltd board of directors approved the reappointment of five directors for five-year terms and scheduled its sixth annual general meeting for September 29, 2026. The decision was taken during a board meeting held on September 4, 2026.
The company also approved the Director's Report for the financial year ended March 31, 2026. Shareholder approval is required for all director reappointments and remuneration fixes at the upcoming general meeting.
Director Reappointments
The board approved the following reappointments, effective from their respective dates:
- Samir Narendra Shah: Reappointed as Chairman and Managing Director effective December 22, 2026.
- Shrenik Kamlesh Shah: Reappointed as Whole-Time Director effective October 1, 2026.
- Parshva Vinaykant Doshi: Reappointed as Non-Executive Independent Director effective December 22, 2026.
- Seema Ashim Jhaveri: Reappointed as Non-Executive Independent Director effective December 22, 2026.
- Yogesh Ramgopal Gupta: Reappointed as Non-Executive Independent Director effective December 22, 2026.
All appointments are subject to shareholder approval. The board also approved remuneration exceeding the overall managerial limit under Section 197 of the Companies Act, 2013.
AGM Details
The sixth annual general meeting is scheduled for Tuesday, September 29, 2026, at 12:00 noon. The event will be held at the company's registered office in Bhiwandi, Thane. M/s. Dilip Swarnkar & Associates has been appointed as the scrutinizer for the voting process.
The cut-off date for determining eligible voting members will be fixed as per regulatory guidelines.
Historical Stock Returns for Alkosign
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.49% | -6.62% | 0.0% | 0.0% | -23.15% | 0.0% |
How might the approval of remuneration exceeding the Section 197 limit impact Alkosign's profitability and shareholder returns in the upcoming fiscal year?
What strategic initiatives or operational changes are expected under the continued leadership of the reappointed board members for the 2026-2027 term?
Are there any potential risks of shareholder dissent regarding the director reappointments or the proposed remuneration packages at the September AGM?




























